CARM - Carisma Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.03 0.0 (3.83%)	---	---	---	0.0 (0.0%)	0.0 (7.65%)	---	0.0 (0.0%)

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.23
Diluted EPS:: -0.23
Basic P/E:: -0.153
Diluted P/E:: -0.153
RSI(14) 1m:: 2.0
VWAP:: 0.04
RVol:: 0.9056

Events

Period	Kind	Movement	Occurred At
10m	Price decrease 10m	0.03 -0.0 (-3.21%)	Oct 15 12:27
1m	Price decrease 1m	0.03 -0.0 (-2.58%)	Oct 15 12:27
10m	Price decrease 10m	0.03 -0.0 (-7.21%)	Oct 15 11:44
10m	Price decrease 10m	0.03 -0.0 (-5.94%)	Oct 15 11:36
10m	Price increase 10m	0.03 +0.0 (+5.94%)	Oct 15 11:34